Puma Biotechnology (PBYI) Accounts Payables (2009 - 2026)
Puma Biotechnology (PBYI) reported Accounts Payables of $3.11 million for Q2 2026, down 42.8% from $5.42 million a year earlier and down 62.0% from the prior quarter.
Powered by 
Analysis
Puma Biotechnology (PBYI) Accounts Payables (2009 - 2026) Analysis & Trends
At the end of FY2025, Puma Biotechnology posted Accounts Payables of $5.06 million, down 8.2% from FY2024.
- Accounts Payables has a five-year compound annual growth rate of -16.0% (FY2020 to FY2025).
- By year, Accounts Payables came in at $5.51 million in FY2024 (-20.0%), $6.89 million in FY2023 (+7.0%), $6.44 million in FY2022 (-42.4%) and $11.17 million in FY2021 (-7.5%).
- The Q2 2026 figure ranks as the lowest quarterly Accounts Payables since Q4 2012.
- Year over year, Accounts Payables gained in two of the last eight quarters, with an average decline of 11.8%.
- The high point for year-over-year Accounts Payables in five years was Q2 2024 (growth of 73.2%); the low point was Q3 2023 (a decline of 66.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $8.17 million (Q1 2026), $5.06 million (Q4 2025) and $6.39 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 9.32 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.03 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -23.57 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Puma Biotechnology | 420.82 Mn | 19.27 Mn | 39.86 Mn | 5.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.06 Mn |
| Jun 30, 2026 | 3.11 Mn |
| Mar 31, 2026 | 8.17 Mn |
| Dec 31, 2025 | 5.06 Mn |
| Sep 30, 2025 | 6.39 Mn |
| Jun 30, 2025 | 5.42 Mn |
| Mar 31, 2025 | 6.03 Mn |
| Dec 31, 2024 | 5.51 Mn |
| Sep 30, 2024 | 7.51 Mn |
| Jun 30, 2024 | 13.50 Mn |
| Mar 31, 2024 | 8.96 Mn |
| Dec 31, 2023 | 6.89 Mn |
| Sep 30, 2023 | 5.06 Mn |
| Jun 30, 2023 | 7.80 Mn |
| Mar 31, 2023 | 8.59 Mn |
| Dec 31, 2022 | 6.44 Mn |
| Sep 30, 2022 | 14.93 Mn |
| Jun 30, 2022 | 9.84 Mn |
| Mar 31, 2022 | 7.41 Mn |
| Dec 31, 2021 | 11.17 Mn |
API Access
Puma Biotechnology Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=PBYI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();